These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21631372)

  • 1. Tailoring combination oral contraceptives to the individual woman.
    Archer DF; Lasa IL
    J Womens Health (Larchmt); 2011 Jun; 20(6):879-91. PubMed ID: 21631372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.
    Stanczyk FZ; Archer DF; Bhavnani BR
    Contraception; 2013 Jun; 87(6):706-27. PubMed ID: 23375353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation.
    Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1085-1098. PubMed ID: 30325245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.
    Roach RE; Helmerhorst FM; Lijfering WM; Stijnen T; Algra A; Dekkers OM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011054. PubMed ID: 26310586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives: mechanism of action, dosing, safety, and efficacy.
    Sondheimer SJ
    Cutis; 2008 Jan; 81(1 Suppl):19-22. PubMed ID: 18338654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophysiologic and clinical aspects of oral contraceptives.
    Balin H; Newton RE; Hontz AC; LoSciuto LA
    Semin Drug Treat; 1973; 3(2):121-42. PubMed ID: 4131558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogens in oral contraception: considerations for tailoring prescription to women's needs.
    Fruzzetti F; Fidecicchi T; Gambacciani M
    Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):93-102. PubMed ID: 38683756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined oral contraceptives: update recommendations of the Latin American contraceptive association.
    Palacios S; Ayala G; González G; Badilla-Apuy CL; Marchena J; Martínez K; Mostajo D; Vernaza MS; Paradas A; Hernández L; Vásquez-Awad D; Celis-González C; de Melo NR
    Gynecol Endocrinol; 2023 Dec; 39(1):2271072. PubMed ID: 37857350
    [No Abstract]   [Full Text] [Related]  

  • 12. Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations.
    Stanczyk FZ; Archer DF
    Contraception; 2014 Apr; 89(4):242-52. PubMed ID: 24485094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.
    Zimmerman Y; Eijkemans MJ; Coelingh Bennink HJ; Blankenstein MA; Fauser BC
    Hum Reprod Update; 2014; 20(1):76-105. PubMed ID: 24082040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of progestins on hemostasis.
    Schindler AE
    Maturitas; 2003 Dec; 46 Suppl 1():S31-7. PubMed ID: 14670643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
    Gaspard U; Lambotte R
    Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication of the month. A new combined oral contraceptive containing estradiol valerate and dienogest (Qlaira)].
    Gaspard U; Pintiaux A; Kridelka F
    Rev Med Liege; 2010 Dec; 65(12):706-13. PubMed ID: 21287768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of combined oral contraception: improving the risk-to-benefit ratio.
    Burkman R; Bell C; Serfaty D
    Contraception; 2011 Jul; 84(1):19-34. PubMed ID: 21664507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined estrogen-progestin oral contraceptives and female sexuality: an updated review.
    Krapf JM; Goldstein AT
    Sex Med Rev; 2024 Jun; 12(3):307-320. PubMed ID: 38515302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.